Morosini Deborah's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Nov 18, 2021
- Accession no.
- 0001209191-21-065616
- Filed
- Nov 18, 2021
- Trade date
- Nov 16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $456.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morosini DeborahCIK 0001824625 | Officer (EVP, Chief of Clinical Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | Common Stock | MOption exerciseAcquired | +28,751 | $12.85 | +$369,450.35 | 29,195 | Direct | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −28,351 | $15.87 | −$449,930.37 | 844 | Direct | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −400 | $16.43 | −$6,572 | 444 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | Common Stock | MOption exerciseDisposed | −28,751 | $0.00 | $0 | 196,045 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.